Q-Line Biotech Limited SME
QLINE · NSE · Listed
· qlinebiotech.com
Issue price
₹343
Listing price
% vs. issue price
₹452
(+31.8%)
Current price
% vs. issue price
₹547.50
(+59.6%)
Lot size
400 shares
Issue size
₹214.48 Cr
Timeline
Open
21 May 2026
Close
25 May 2026
Allotment
26 May 2026
Settlement
27 May 2026
Listing
29 May 2026
Mandate end
9 Jun 2026
Anchor 50%
25 Jun 2026
Anchor 100%
24 Aug 2026
The timeline is tentative. Anchor unlock dates apply only to IPOs with an anchor allotment.
Subscription
| Quota | Shares offered (₹ Cr) |
Shares applied (₹ Cr) |
Times subscribed |
|---|---|---|---|
| QIB | 40.75 | 5,050.24 | 123.94x |
| NII | 30.58 | 4,475.01 | 146.33x |
| IND | 71.32 | 5,094.98 | 71.44x |
| Total | 142.65 | 14,620.22 | 102.49x |
| Quota | Applications reserved |
Applications received |
Times subscribed |
|---|---|---|---|
| QIB | 2,970 | 197 | 0.07x |
| NII | 743 | 49,781 | 67.00x |
| IND | 2,599 | 1,85,677 | 71.44x |
| Total | 6,312 | 2,35,655 | 37.33x |
Last updated: just now
Application size
| Quota | Min | Max |
|---|---|---|
| IND |
2 lots · ₹2,74,400
|
2 lots · ₹2,74,400
|
| sNII |
3 lots · ₹4,11,600
|
7 lots · ₹9,60,400
|
| bNII |
8 lots · ₹10,97,600
|
No limit
funds permitting
|
Based on the upper price band of ₹343.
Intermediaries
- Lead managers
- Hem SecuritiesShare India Capital Services
- Registrar
- Purva Sharegistry (India)
- Market maker
- Hem Finlease